Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure
- PMID: 22212979
- DOI: 10.1002/pros.22473
Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure
Abstract
Background: Castration-resistant prostate cancers (CRPCs) overexpress often androgen receptor (AR). Here, we investigated the effect of AR overexpression on the dynamics of AR loading and RNA polymerase II (RNA Pol II) recruitment to chromatin. Acetylation of histone 3 (AcH3) on lysines 9 and 14 (K9 and K14) was also studied.
Methods: We used an LNCaP-based AR overexpression cell line model that includes a control line and two sublines, LNCaP-ARmo and LNCaP-ARhi, which overexpress AR twofold to threefold and fourfold to fivefold, respectively. Cells were exposed to 1 or 100 nM of dihydrotestosterone (DHT). Chromatin immunoprecipitation (ChIP) on the promoters and enhancers of prostate specific antigen (PSA) and transmembrane protease, serine 2 (TMPRSS2) genes was performed. qRT-PCR was used to measure the levels of PSA and TMPRSS2 transcripts.
Results: Upon stimulation with 1 nM DHT, AR and RNA Pol II were recruited onto PSA and TMPRSS2 enhancer regions to a greater extent (P < 0.05) in AR-overexpressing cells compared to control cells. The difference in AR loading between the control and AR-overexpressing cells was abolished by a higher DHT concentration. The ratio of AcH3/H3 was increased in AR-overexpressing cells. The induction of transcription of PSA and TMPRSS2 occurred earlier in the AR-overexpressing cells.
Conclusions: Our findings suggest that the levels of AR potentiate the recruitment of the AR, as well as components of the basic transcription machinery, to chromatin and affect the acetylation of histones in the presence of low levels of androgens. These changes result in enhanced gene transcription of AR target genes.
Copyright © 2011 Wiley Periodicals, Inc.
Similar articles
-
Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.Mol Cancer Res. 2003 Mar;1(5):385-92. Mol Cancer Res. 2003. PMID: 12651911
-
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens.Cancer Res. 2009 Oct 15;69(20):8141-9. doi: 10.1158/0008-5472.CAN-09-0919. Epub 2009 Oct 6. Cancer Res. 2009. PMID: 19808968
-
Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.Oncogene. 2011 Feb 3;30(5):619-30. doi: 10.1038/onc.2010.436. Epub 2010 Oct 4. Oncogene. 2011. PMID: 20890304
-
Chromatin binding by the androgen receptor in prostate cancer.Mol Cell Endocrinol. 2012 Sep 5;360(1-2):44-51. doi: 10.1016/j.mce.2011.09.037. Epub 2011 Oct 2. Mol Cell Endocrinol. 2012. PMID: 21989426 Review.
-
Androgen receptor enhancer usage and the chromatin regulatory landscape in human prostate cancers.Endocr Relat Cancer. 2019 May;26(5):R267-R285. doi: 10.1530/ERC-19-0032. Endocr Relat Cancer. 2019. PMID: 30865928 Review.
Cited by
-
Combining epigenetic drugs with other therapies for solid tumours - past lessons and future promise.Nat Rev Clin Oncol. 2020 Feb;17(2):91-107. doi: 10.1038/s41571-019-0267-4. Epub 2019 Sep 30. Nat Rev Clin Oncol. 2020. PMID: 31570827 Review.
-
Molecules targeting the androgen receptor (AR) signaling axis beyond the AR-Ligand binding domain.Med Res Rev. 2019 May;39(3):910-960. doi: 10.1002/med.21548. Epub 2018 Nov 22. Med Res Rev. 2019. PMID: 30565725 Free PMC article. Review.
-
Epigenomic Regulation of Androgen Receptor Signaling: Potential Role in Prostate Cancer Therapy.Cancers (Basel). 2017 Jan 16;9(1):9. doi: 10.3390/cancers9010009. Cancers (Basel). 2017. PMID: 28275218 Free PMC article. Review.
-
Epigenetic polypharmacology: A new frontier for epi-drug discovery.Med Res Rev. 2020 Jan;40(1):190-244. doi: 10.1002/med.21600. Epub 2019 Jun 20. Med Res Rev. 2020. PMID: 31218726 Free PMC article. Review.
-
Nuclear export signal of androgen receptor (NESAR) regulation of androgen receptor level in human prostate cell lines via ubiquitination and proteasome-dependent degradation.Endocrinology. 2012 Dec;153(12):5716-25. doi: 10.1210/en.2012-1841. Epub 2012 Oct 5. Endocrinology. 2012. PMID: 23041672 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous